Myriad Genetics Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Myriad Genetics Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Myriad Genetics Inc. stocks after a simple registration process. </div>

Q: How to buy Myriad Genetics Inc. shares in India?

<div> To buy Myriad Genetics Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Myriad Genetics Inc. and you are done!</div> </div>

Q: What is the share price of Myriad Genetics Inc.?

<div>The share price of Myriad Genetics Inc. is USD 13.35 as on 20 Dec.</div>

Q: What is the Market Capitalization of Myriad Genetics Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Myriad Genetics Inc. is USD 1.22B as on 20 Dec.</div>

Q: What is the PE ratio of Myriad Genetics Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Myriad Genetics Inc. is N/A as on 20 Dec. </div>

Q: Is Myriad Genetics Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Myriad Genetics Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Myriad Genetics Inc. operate?

<div> Myriad Genetics Inc. operates in Healthcare / Diagnostics & research

Healthcare Diagnostics & research

$13.35

+0.18

(20 Dec)

Loading Chart

Previous close

$13.35

Open

$13.35

Today’s high

$13.56

Today’s low

$13.04

52W low

$12.87

52W high

$29.3

-34.72%

-13.38%

EPS (TTM)

-1.28

Shares O/S

91.04M

Market cap

1.22B

Insights

MYGN price is above its 200 day moving average

MYGN is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.

In beta. Send feedback here.

Compare with other stock

About Myriad Genetics Inc.

Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health.

In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor Test, Precise Liquid Test, SneakPeek and GeneSight, among others. .

FAQs

Can I buy Myriad Genetics Inc. shares in India?

How to buy Myriad Genetics Inc. shares in India?

What is the share price of Myriad Genetics Inc.?

What is the Market Capitalization of Myriad Genetics Inc.?

What is the PE ratio of Myriad Genetics Inc.?

Is Myriad Genetics Inc. a good stock to buy?

In which sector / industry does Myriad Genetics Inc. operate?